Icon

TEMBEXA (nda214460)- (10MG/ML)

BRINCIDOFOVIR EMERGENT BIODEFENSE
10MG/ML
No No
2031-Aug-31 Expired
None 2024-Jun-04
None No
TEMBEXA is an orthopoxvirus nucleotide analog DNA polymerase inhibitor and is indicated for the treatment of human smallpox disease in adult and pediatric patients, including neonates.
0 0 0
Total Other Developers None
Drugs with Suitability No
10MG/ML ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.